Extensive animal studies have indicated that antenatal betamethasone exposure results in altered developmental trajectories of several fetal systems. Follow up of a randomized controlled trial has shown that antenatal betamethasone exposure might result in insulin resistance 30 years later. Furthermore, animal studies and randomized trials in Humans have clearly demonstrated that betamethasone-induced growth alterations were dose-related. In ewes, a 50% reduced dose regimen resulted in maximal improvement in preterm lamb lung function, similar to those obtained after a full dose. Our hypothesis is that antenatal betamethasone after a 50% dose reduction, justified by the potential long term effects of this drug, is not inferior to a full dose to promote fetal lung maturation in Humans.
The BETADOSE project consist in a randomized, multicenter, double blind placebo-controlled non inferiority trial comparing a standard dose regimen (24 mg) to a reduced dose regimen (12 mg) of betamethasone given to prevent the neonatal complications associated with very preterm birth.A betamethasone course consists in 2 injections of 12 mg betamethasone 24 hours apart for a total dose of 24 mg. The first injection will be unmasked in both group. In both group, women will receive a first 12 mg injection of betamethasone according to local protocols. Randomization will be performed after the first injection. Women will then receive either a placebo injection (reduced dose regimen, 12 mg only from the first injection) or a second 12 mg betamethasone injection (standard dose regimen, 12 mg from the first injection and 12 mg from the second injection=24 mg). This protocol allows women sent from level 1 and 2 to level 3 perinatal centers after having already received their first injection to participate. In case of multiple antenatal betamethasone courses, women will receive their second course according to the same design as in their first course.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
3,250
Hôpital Robert Debré
Paris, France
severe RDS defined as need for exogenous intra-tracheal surfactant in the first 48 hours of life
The primary assessment criterion is severe respiratory distress syndrome(RDS) defined as need for exogenous intra-tracheal surfactant in the first 48 hours of life. It is considered as a binary endpoint: failure if there is occurrence of RDS, or not failure.
Time frame: 48 hours of life
highest appropriate fractional inspired oxygen (FiO2)
Time frame: 48 hours of life
maximum appropriate Mean Airway Pressure (MAP)
Time frame: 48 hours of life
duration of mechanical ventilation
Time frame: 36 weeks post conception
duration of oxygen therapy
Time frame: 36 weeks post conception
oxygen therapy
Time frame: 36 weeks post conception
neonatal death
Time frame: 36 weeks post conception
admission to neonatal intensive care unit
Time frame: 36 weeks post conception
inotropic support
Time frame: 36 weeks post conception
air leak syndrome
Time frame: 36 weeks post conception
patent ductus arteriosus
Time frame: 36 weeks post conception
necrotising enterocolitis
Time frame: 36 weeks post conception
intraventricular hemorrhage and grade
Time frame: 36 weeks post conception
periventricular leukomalacia
Time frame: 36 weeks post conception
use of postnatal steroids
Time frame: 36 weeks post conception
retinopathy of prematurity
Time frame: 36 weeks post conception
length of hospital stay
Time frame: 36 weeks post conception
early onset sepsis
Time frame: 36 weeks post conception
Composite endpoint of any of the 4 prematurity-induced complications related to the use of betamethasone
Related to betamethasone impact on other prematurity-induced complications, is a composite outcome taking into account multiple clinical events : neonatal death, severe RDS defined as need for exogenous intra-tracheal surfactant in the first 48 hours of life, intraventricular hemorrhage high grade, and necrotising enterocolitis.
Time frame: 36 weeks post conception
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.